Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug mixing and delivery system and method

a technology of drug mixing and delivery system, applied in the direction of drug composition, peptide/protein ingredient, metabolic disorder, etc., can solve the problems of hives, anaphylactic shock, sharp drop in blood pressure, etc., to improve stability, potency and/or chiral stability, and long shelf life

Inactive Publication Date: 2015-08-20
WINDGAP MEDICAL
View PDF7 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent relates to a method of making drug compositions that can be quickly dissolved and reconstitutable for delivery to a patient. These dry compositions have several advantages over liquid compositions, including increased stability and shelf life. The dry drug composition is prepared by drying a drug solution using methods like vacuum drying, freeze drying, or lyophilizing. The dry drug can be placed inside an autoinjector as a dry powder and can have a small particle size for efficient and rapid reconstitution. This results in a medicament that can be stored as a dry medication with extended shelf-life, reduced temperature susceptibility, and greater efficacy and potency to endure over a longer period of time and through a wider range of temperature environments.

Problems solved by technology

Exposure to certain substances, such as, for example, peanuts, shellfish, bee venom, certain drugs, toxins, and the like, can cause allergic reactions in sensitive individuals.
Such allergic reactions can lead to anaphylactic shock.
This can cause a sharp drop in blood pressure, hives, and / or severe airway constriction and can be a life-threatening condition.
For patients that are required to carry epinephrine autoinjectors with them, the thermal stability profile of the medication can present an issue.
Not doing so can degrade the medication rapidly and result in a drug that doesn't have the recommended potency to deal with the onsets of anaphylactic shock.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug mixing and delivery system and method
  • Drug mixing and delivery system and method
  • Drug mixing and delivery system and method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0035]Provided herein are methods of preparing a medical solution comprising a therapeutic agent. In some embodiments, aspects of the invention relate to stabilizing a drug and making it less susceptible to temperature-induced degradation, by preparing a dry composition (e.g., a dry salt form) of the drug that can be readily reconstituted (e.g., in the context of an autoinjector) for delivery to a patient.

[0036]The dry composition can be prepared from any suitable method as used in the pharmaceutical formulation. For example, a drug may be chemically derived, lyophilized (freeze-dried) and / or spray dried and / or using any other technique to put the drug and / or medicament into a dry form. However, in some embodiments, it is important that the dried drug be easily and rapidly soluble so that the dry composition can be used in an autoinjector that also contains a liquid component that can be mixed with the dry drug to solubilize it upon activation of the autoinjector (e.g., immediately ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Concentrationaaaaaaaaaa
Solubility (mass)aaaaaaaaaa
Login to View More

Abstract

The present disclosure provides methods of preparing a medical solution. In some aspects, the medical solution can be prepared from mixing a first liquid with a second liquid or mixing a solid component with a liquid in an autoinjector. In some aspects, the heat released from the mixing can promote solubility of a dry medicament in the solution.

Description

RELATED APPLICATIONS[0001]The present invention claims priority under 35 U.S.C. §119(e) to U.S. provisional patent applications, U.S. Ser. No. 61 / 917,925, filed Dec. 18, 2013, and U.S. Ser. No. 62 / 016,260, filed Jun. 24, 2014, the entire contents of each of which are incorporated herein by reference.BACKGROUND OF INVENTION[0002]Individuals who suffer from certain medical conditions are often required to keep an auto-injector or prefilled syringe nearby in order to address a medical need. A few examples of this are insulin pens for people with diabetes, epinephrine autoinjectors for those with food and insect stings allergies, and antidotes for soldiers at risk of exposure to chemical and / or biological toxins in the field.[0003]Exposure to certain substances, such as, for example, peanuts, shellfish, bee venom, certain drugs, toxins, and the like, can cause allergic reactions in sensitive individuals. Such allergic reactions can lead to anaphylactic shock. This can cause a sharp drop...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61M5/24A61M5/28A61K31/4045A61K31/137A61K38/26
CPCA61K31/137A61K38/00A61K45/06A61K31/4045A61K9/0019A61M5/19A61M5/2046A61M5/3294A61M5/44A61M2205/364A61M2205/366A61M5/1409A61K38/26A61P25/06A61P3/08A61P9/02A61M5/2448A61M5/284
Inventor BUCHINE, BRENT A.STANDLEY, ADAM R.STEPANIAN, CHRISTOPHER J.
Owner WINDGAP MEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products